SCHEMBL25540751

SCHEMBL25540751

c1ccc(-c2cc(-c3ccccc3)nc(-c3ccc(-c4ccc(-c5ccc6c(c5)-c5cc7ccccc7cc5C6(c5ccccc5)c5ccccc5)cc4)c4ccccc34)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.37
ALDH1A1 P00352 5/20 0.37
HPGD P15428 5/20 0.37
MEN1 O00255 5/20 0.37
KMT2A Q03164 5/20 0.37
ACACA Q13085 3/20 0.36
CYP1A1 P04798 1/20 0.35
CYP1B1 Q16678 1/20 0.35
KDM4E B2RXH2 3/20 0.34
NTSR1 P30989 1/20 0.34
LMNA P02545 2/20 0.33
GLA P06280 1/20 0.33
TP53 P04637 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33
HIF1A Q16665 1/20 0.33
HSD17B10 Q99714 1/20 0.33
CTRC Q99895 1/20 0.33
DHODH Q02127 1/20 0.33
PDK2 Q15119 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25540614 0.96 MEN1 (0.38) MAPTALDH1A1HPGDMEN1KMT2A
SCHEMBL25540754 0.96 MAPT (0.34) MAPTALDH1A1HPGDMEN1KMT2A
SCHEMBL25540612 0.95 MEN1 (0.38) MAPTALDH1A1HPGDMEN1KMT2A
SCHEMBL25540711 0.95 ALDH1A1 (0.38) MAPTALDH1A1HPGDMEN1KMT2A
SCHEMBL25540618 0.94 MAPT (0.36) MAPTALDH1A1HPGDMEN1KMT2A
SCHEMBL25540755 0.94 MEN1 (0.36) MAPTALDH1A1HPGDMEN1KMT2A
SCHEMBL25540756 0.94 MEN1 (0.38) MAPTALDH1A1HPGDMEN1KMT2A
SCHEMBL25538645 0.93 MEN1 (0.41) MAPTALDH1A1HPGDMEN1KMT2A
SCHEMBL25540625 0.92 MAPT (0.35) MAPTALDH1A1HPGDMEN1KMT2A
SCHEMBL25540525 0.92 MEN1 (0.39) MAPTALDH1A1HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM MAPT 1595/4885ALDH1A1 254/4885HPGD 3854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.